1. P01.147 Recurrent glioblastoma or therapy-related changes: The diagnostic accuracy of O-(2-[18F]-fluoroethyl)-L-tyrosine PET imaging. (19th September 2018) Authors: Bashir, A; Jacobsen, S; Urup, T; Broholm, H; Grunnet, K; Møller, S; Henriksen, O; Larsen, V; Skjøth-Rasmussen, J; Skovgaard Poulsen, H; Law, I Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P02.05.B Targeted therapies of Glioblastoma using single cell sequencing and drug-response analysis in a phase 2 clinical trial setting. (5th September 2022) Authors: Lü, M; Hendriksen, J; Urup, T; Hamerlik, P; Wennerberg, K; Lassen, U; Skovgaard, H; Weischenfeldt, J Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P11.32.A EGFR expression and non-methylated MGMT predict distant recurrence in glioblastoma patients treated with standard therapy. (5th September 2022) Authors: Urup, T; Trip, A K; Chiranth, S B; Christensen, I J; Grunnet, K; Møller, S; Hasselbalch, B; Muhic, A; Lassen, U; Poulsen, H S Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗